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Nicotine is a major addictive compound in cigarettes and is rapidly and extensively metabolized to several 
metabolites in humans, including urinary cotinine, considered a biomarker due to its high concentration 
compared to other metabolites. The aim of this study was to develop a single method for determination 
of urinary cotinine, in active and passive smokers, by gas chromatography with a nitrogen phosphorus 
detector (GC-NPD). Urine (5.0 mL) was extracted with 1.0 mL of sodium hydroxide 5 mol L-1, 5.0 mL 
of chloroform, and lidocaine used as the internal standard. Injection volume was 1 µL in GC-NPD. 
Limit of quantification was 10 ng mL-1. Linearity was evaluated in the ranges 10-1000 ng mL-1 and 500-
6000 ng mL-1, with determination coefficients of 0.9986 and 0.9952, respectively. Intra- and inter-assay 
standard relative deviations were lower than 14.2 %, while inaccuracy (bias) was less than +11.9%. The 
efficiency of extraction was greater than 88.5%. Ruggedness was verified, according to Youden’s test. 
Means of cotinine concentrations observed were 2,980 ng mL-1 for active smokers and 132 ng mL-1, for 
passive smokers. The results revealed that satisfactory chromatographic separation between the analyte 
and interferents was obtained with a ZB-1 column. This method is reliable, precise, linear and presented 
ruggedness in the range evaluated. The results suggest that it can be applied in routine analysis for 
passive and active smokers, since it is able to quantify a wide range of cotinine concentrations in urine. 
Uniterms: Gas chromatography/with nitrogen phosphorus detector. Urinary cotinine/determination. 
Urine/toxicological analysis. Smokers/Toxicology.
A nicotina é uma substância presente no cigarro capaz de causar dependência, sendo biotransformada em 
vários metabólitos nos seres humanos, dentre eles a cotinina urinária, que é considerada um indicador 
biológico de exposição à nicotina, devido a suas altas concentrações, comparado a outras matrizes. Assim, 
o objetivo deste estudo foi desenvolver um único método para determinação de cotinina urinária, em 
amostras de urina de fumantes ativos e passivos, através de cromatografia em fase gasosa com detector 
de nitrogênio- fósforo (CG-DNF). Para o preparo de amostras foram utilizados 5 mL de urina, 1 mL de 
hidróxido de sódio 5 mol L-1, 5 mL de clorofórmio, tendo como padrão interno a lidocaína. Na faixa 
de concentrações de 10-1000 ng mL-1 e 500- 6000 ng mL-1, o coeficiente de determinação foi 0,9986 
e 0,9952, respectivamente e, o limite de quantificação foi 10 ng mL-1. A precisão intra- e interensaio 
apresentou desvio padrão relativo (%) menor que 14,2% e a inexatidão foi menor que +11,9%, com uma 
eficiência de extração de 88,5%. O método apresentou robustez, de acordo com o teste de Youden. As 
concentrações médias de cotinina observadas foram 2980 ng mL-1, para fumantes ativos e 132 ng mL-1, 
para fumantes passivos. Os resultados sugerem que o método é confiável, preciso, linear e apresentou 
robustez, na faixa avaliada, podendo ser aplicado na rotina para análises de amostras de fumantes ativos 
e passivos, pois é capaz de quantificar uma ampla faixa de concentrações de cotinina urinária.
Unitermos: Cromatografia em fase gasosa/com detector de nitrogênio-fósforo/análise quantitativa. 
Cotinina urinária/determinação. Urina/análise toxicológica Fumantes/Toxicologia.
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INTRODUCTION
It is well known that tobacco smoke, which contains 
many toxic and tumorigenic compounds, is recognized as 
a major cause of mortality and morbidity (Richard, Eian, 
Graham, 2004). Tobacco is the single most preventable 
cause of death in the world today. By 2030, the death toll 
will exceed eight million a year (WHO, 2008).
More than 4000 compounds have been identified in 
tobacco smoke in which nicotine is the principal alkaloid 
(Hansen et al., 2001). Nicotine, a major chemical found 
in all tobacco products, is present in both mainstream 
and sidestream tobacco smoke. In both smokers and non-
smokers, nicotine enters the bloodstream when tobacco 
smoke is inhaled. It is then circulated to various body 
organs (Benowitz, 1996).
Cotinine is the major proximate metabolite of nico-
tine and has been widely used as a biomarker of tobacco 
smoke exposure (Kuo, Yang, Chiu, 2002) and offers sev-
eral advantages over biochemical markers as an objective 
indicator of nicotine intake or confirmation of non-smoker 
status. Its concentrations are not influenced by other sub-
stances since it is a specific nicotine biomarker and con-
centrations within a given individual varies by only 15 to 
20% over 24 h (Oddoze, Pauli, Pastor, 1998). Cotinine in 
urine accounted for less than 15% of total systemic dose 
of nicotine (Cope et al., 1996; Benowitz, 1996).
The half-life of cotinine and nicotine are approxi-
mately 19 and 2 h, respectively. Consequently, cotinine, 
because of its longer half-life, is currently the marker of 
choice for demonstrating cigarette smoke exposure (Hau-
froid, Lison, 1998). Its determination in biological fluids 
has aroused particular interest. These biochemical mark-
ers have been used to estimate active smoking behavior, 
to validate abstinence from smoking and to evaluate the 
levels and significance of environmental tobacco smoke 
(ETS) exposure (Benowitz, 1996). Urinary samples are 
more convenient to collect and urinary cotinine is a well-
known biomarker of ETS (Jarvis et al., 1987; Wall et al., 
1988; Kuo, Yang, Chiu, 2002).
Many methods have been proposed for the determina-
tion of cotinine in human urine. These methods use radio-
immunoassay (Kuo, Yang, Chiu, 2002); high performance 
liquid chromatography (Zuccaro et al., 1995; Oddoze, Pauli, 
Pastor, 1998; Tyrpien et al., 2000; Abou-Qare, Abou-Donia, 
2001; Doctor et al., 2004; Kowalski et al., 2007) and gas 
chromatography with nitrogen phosphorus detection (Kuo, 
Yang, Chiu, 2002; Moriya, Hashimoto, 2004). Liquid or gas 
chromatography coupled mass spectrometry is commonly 
employed to determine cotinine in passive smokers (Ji Jr. et 
al., 1999; Meger et al., 2002; Man et al., 2006; Chadwick, 
Keevil, 2007). Other less sensitive detectors, such as flame 
ionization detector (FID), have also been used to quantify 
cotinine in urine of active and passive smokers. However, 
the sample preparation needed larger urine volume (25 mL) 
(Vacchino et al., 2006). 
Among these methods, the chromatographic tech-
niques are more preferred than others because they are 
potentially more sensitive and more specific. This fact is 
due to sample enrichment by extraction prior to analysis 
and sample cleanup through chromatographic separation 
during analysis (Song et al., 2005). In this context, many 
methods have been proposed for extraction of samples 
containing cotinine, among then, liquid-liquid extraction 
(LLE) (Shin et al., 2002; Man et al., 2006; Kowalski et 
al., 2007) and solid phase extraction (SPE) (Oddoze, Pauli, 
Pastor, 1998; Moyer et al., 2002; Xu, Iba, Weisel, 2004). 
LLE presents the advantages of being a simple 
method of sample preparation that can use a great number 
of solvents, pure and available commercially, which sup-
ply a wide range of solubility and selectivity (Queiroz, 
Collins, Jardim, 2001).
The aim of this study was to develop a single method 
able to determine urinary cotinine, in active and passive 
smokers, by GC-NPD with a previous LLE.
MATERIAL AND METHODS
Reagents and standard solutions
Cotinine (COT) with approximately 98% purity (Lot 
no. 055k4053) and lidocaine (LID) with approximately 
98% purity (Lot no. 162008), were purchased from Sigma-
Aldrich Inc. (St. Louis, USA). Analytical grade isopropyl 
alcohol and chloroform were purchased from Vetec Ltda. 
(Rio de Janeiro, Brazil), methyl alcohol from Isofar Ltda. 
(Rio de Janeiro, Brazil) and sodium hydroxide from La-
bsynth Ltda. (São Paulo, Brazil).
Stock solutions of cotinine and lidocaine (internal 
standard) were prepared in isopropyl alcohol at 1 mg mL-1 
and stored at -20oC, protected from light. These solutions 
were used for at least one month. Working solutions were 
freshly prepared in isopropyl alcohol immediately before 
analysis. Throughout the study, water was obtained from 
a Milli-Q system by Millipore (São Paulo, Brasil).
Instrumentation and chromatographic conditions
The GC system consisted of a GC model Clarus 
400, equipped with NPD from Perkin Elmer® with Total-
chrom Workstation® Software. Chromatographic analysis 
was performed in a ZB-1 column Phenomenex® (100% 
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polydimethylsiloxane, 30 m x 0.53 mm i.d.; 5 µm film 
thickness). Nitrogen was used as a gas carrier at a pressure 
of 4.3 psi. One microliter injection volume using splitless 
mode was injected manually, at an injector temperature 
of 260 oC. The oven temperature was programmed from 
180 oC increasing by 30 oC/minute to 250 oC for 0.5 min, 
increasing by 15 oC/min to 259 oC for 0.1 min and then in-
creasing by 0.1 oC/min to 260 oC. The detector temperature 
was 280 oC. The total run time was 13.4 min.
Urine samples
Cotinine-free urine, sourced from non-smokers not 
exposed to environmental nicotine, was used as a blank 
matrix to perform validation parameters. Urine samples 
from forty-one active smokers, ten passive smokers 
and eighteen unexposed non-smokers were used for 
application of this method. This study was approved by 
the Ethics Committee of Federal University of Alfenas 
(23087.002423/2008-12). An informed consent term was 
obtained from each volunteer.
All samples were collected in polyethylene urine 
containers and density was measured at each sampling 
time with a refractometer (Atago®) for standardization of 
cotinine levels. Samples were then frozen and stored at 
-20 oC until analysis.
Sample preparation
Before extraction, samples were thawed and equi-
librated to room temperature. Urine (5.0 mL) was placed 
in a 15 mL centrifuge glass tube. Sodium hydroxide 
(5 mol L-1, 1 mL), lidocaine as the internal standard (500 or 
1000 mg mL-1, 0.05 mL) and chloroform (5.0 mL) were 
added and the mixture was mixed for 15 minutes in a bench 
top shaker. After centrifugation for 15 minutes at 840 g, the 
aqueous layer was discarded and 4.5 mL of organic phase 
was transferred into a conical glass tube. The extract was 
evaporated in a stream of nitrogen, within a bath at 40 oC. The 
residue was reconstituted in 0.05 mL of isopropyl alcohol.
Method validation
Appropriate validation is necessary to ensure the 
suitability of analytical methods for the purpose (Kowalski 
et al., 2007), and the confidence parameters of the present 
method were assayed according to the Guidance for In-
dustry of the FDA for Bioanalytical Method Validation 
(2001). The parameters evaluated in the present study 
were: linearity, limit of quantification, recovery, intra- and 
inter-assay precision, accuracy and ruggedness.
The linearity was studied in two linear ranges (10-
1000 ng mL-1 and 500-6000 ng mL-1) to minimize errors 
from a wide range of urinary cotinine concentrations. 
Urine samples were spiked with COT at concentrations 10; 
100; 250; 500; 750; 1000 ng mL-1 and 500; 1000; 2000; 
3000; 4000; 6000 ng mL-1, and each treatment was assayed 
in six replicates. Concentration of internal standard was 
adjusted according to the range evaluated (500 mg mL-1, 
for 10-1000 ng mL-1 of cotinine or 1000 mg mL-1 for 500-
6000 ng mL-1, of cotinine).
These samples were analyzed according to the item 
sample preparation. Calibration curves were constructed 
by plotting peak area ratios of analyte and its internal 
standard versus original concentrations, and evaluated by 
linear least square regression analysis.
The limit of quantification was estimated after suc-
cessive dilutions of cotinine solutions, until obtention of 
a concentration in which the peak area was ten times the 
signal-to-noise ratio (S/N= 10), provided by the blank 
extract (N= background noise).
Recovery was determined by three replicate analyses 
of samples after the additional spiking of a known mass 
of the analyte, in the non-contaminated samples, at three 
levels. The results were compared with those obtained 
when the analyte was spiked after the clean-up procedure 
of the sample, at the same levels.
Intra- assay precision was assessed using three 
replicates of each concentration of linear range, on the 
same day. Inter-assay precision was evaluated for three 
replicates analyzed on separate days (n=6). The results 
were expressed as a percentage of relative standard de-
viation (% RSD).
Accuracy was established by spiking urine sam-
ples with 30, 500, 1000, 3000 and 6000 ng mL-1 of COT
 (n= 3/ concentration). After extraction and chromatogra-
phic analysis, results were compared to the theoretical 
added values.
Ruggedness was evaluated through the Youden 
approach, which is based on a fractional factorial de-
sign according to the Official Journal of the European 
Communities (2002). For this purpose, eight determi-
nations were carried out, combining the nominal and 
with-variation parameters. The variables evaluated are 
described in Table I. The experiments are described in 
Table II, and Table III contains the formula used to eva-
luate the variation effect. 
RESULTS
Figure 1 shows the urinary chromatograms of pas-
sive, active and non-smoker volunteers obtained with the 
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validated method. Lidocaine was used as the internal stan-
dard at concentrations of 500 mg mL-1 in a) non smokers; 
and at 1000 mg mL-1 in b) and c), passive and active 
smokers, respectively. The method revealed satisfactory 
chromatographic separation between the analyte and inter-
ferents, I requiring only a short time for chromatography 
(less than 14 min) and proved suitable for determining the 
cotinine in urine in routine analysis.
LOQ is the lowest concentration of an analyte on a 
calibration curve, and for this method the concentration 
10 ng mL-1 resulted in a signal-to-noise ratio of 10, and 
TABLE I - Robustness parameters
Parameters Nominal (+) Variation (-)
Sample volume (mL) 5.0 4.0
NaOH concentration (mol L-1) 5.0 4.5
Agitation in vortex Yes no
Time in bench top shaker (min) 15 10
Time in centrifuge (min) 15 10
Detector temperature (oC) 280 275
Gas carrier pressure (psi) 4.3 4.2
TABLE II - Combinations assayed for nominal or variable 
parameters
Parameters Combination assayed
1 2 3 4 5 6 7 8
Sample volume (mL) + + + + - - - -
NaOH concentration (mol L-1) + + - - + + - -
Agitation in vortex + - + - + - + -
Time in bench top shaker (min) + + - - - - + +
Time in centrifuge (min) + - + - - + - +
Detector temperature (oC) + - - + + - - +
Gas carrier pressure (psi) + - - + - + + -
Results a b c D e f g h
TABLE III - Variation effects evaluation
Factor Formula for variation effect
Sample volume (a+b+c+d)/4 – (e+f+g+h)/4
NaOH concentration (a+b+e+f)/4 – (c+d+g+h)/4
Agitation in vortex (a+c+e+g)/4 – (b+d+f+h)/4
Time in bench top shaker (a+b+g+h)/4 – (c+d+e+f)/4
Time in centrifuge (a+c+f+h)/4 – (b+d+e+g)/4
Detector temperature (a+d+e+h)/4 – (b+c+f+g)/4
Gas carrier pressure (a+d+f+g)/4 – (b+c+e+h)/4
FIGURE 1 - Chromatograms after LLE of urine: a) non 
smokers; b) passive smokers; c) active smokers. (1) Cotinine: 
rt 5.7 min; k’ 2.0 min; α 1.25 (calculated between cotinine 
and immediately before peak) (2) Lidocaine (IS): rt 8.2 min; 
k’ 3.3 min; α 1.1 (calculated between cotinine and immediately 
after peak). Chromatographic conditions: ZB-1 column, injector 
temperature at 260 oC, the oven temperature programmed with 
initial temperature of 180 oC, ramp 1: 30 oC/ minute to 250 oC 
for 0.5 min; ramp 2: 15 oC/ min to 259 oC for 0.1 min and ramp 
3: 0.1 oC/min to 260oC, detector temperature at 280 oC. Nitrogen 
as gas carrier at 4.3 psi.
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TABLE IV - Linearity of method
COTININE
Linear Range (ng mL-1) 10-1000 500-6000
Slope (a) 0.0036 ± 0.0002 0.0012 ± 7.53 x10-5
Intercept (b) 0.0936 ± 0.061 0.2979 ± 0.203
Determination Coefficient (R2) 0.9986 0.9952
TABLE V - Recovery and accuracy for the analysis of cotinine in urine, by CG-NPD after ELL
COTININE
Urine concentration (ng mL-1) Relative Recovery (mean, %) Accuracy (bias, %)
30 102.2 +11.9
500 99.2 +0.6
1000 88.5 +2.9
3000 104.7 +7.6
6000 108.2 -1.7
Mean 100.6 +4.3
TABLE VI - Intra- and inter-assay precision for the analysis of cotinine in urine, by CG-NPD after ELL. 
Urine concentration (ng mL-1) Intra-assay(n=3)
RSD (%)
Inter-assay (n=6, 2 days)
RSD (%)
10 3.1 14.2
500 4.5 3.4
1000 6.3 4.6
3000 8.5 2.1
6000 3.9 6.7
the % relative standard deviation ( n=5) obtained was 
8.99%. Tables IV, V and VI show the results of the method 
validation.
Ruggedness was assessed using the Youden approa-
ch. Eight determinations were made using a combination 
of the factors with variations (see Table I). Variation in-
fluence was evaluated by comparing the values obtained 
by the formulas in Table III, with those values obtained by 
the proposed method (nominal parameters). Variations of 
more that two standard deviations from the result obtained 
using the proposed method (nominal parameters) were 
considered to indicate that a parameter caused alteration 
in the method. Ruggedness was demonstrated, since no 
statistically significant difference was observed between 
the nominal parameters and the values obtained with the 
variation described in Table II.
The values for cotinine concentrations observed in 
urine were 2,980 ± 2,160 ng mL-1, for active smokers and 
132.00 ± 80 ng mL-1, for passive smokers.
DISCUSSION
Urine is the preferred specimen over plasma and 
saliva because it is much easier to obtain, particularly 
in epidemic studies (Hariharan, Vannoord, 1991). The 
advantages of using urine in the investigations included 
lower viscosity and ease of handling compared with saliva 
or blood, as well as constituting a relatively nonintrusive 
sample collection/ donation method without an occupatio-
nal health risk (Tuomi, Johnsson, Reijula, 1999; Hagan, 
Ramos Jr., Jacob III, 2002). Since urinary cotinine is 
considered a biomarker of exposure to tobacco, the objec-
tive of this study was to develop a single method able to 
determine urinary cotinine in active and passive smokers. 
The literature describes this determination but the sample 
preparation required a high urine volume (25 mL) (Vac-
chino et al., 2006). The present study used 5.0 mL urine.
Among available sample-preparation techniques, 
liquid-liquid extraction is an efficient clean-up procedure 
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for removing unwanted substances from urine matrix and 
can also be used to concentrate the analyte (Kowalski et 
al., 2007).
Due to its pKa (4.5), cotinine is found in greater 
quantity in non-ionized form in the blood (pH 7.4) and 
the free base form is poorly soluble in lipids, showing a 
low rate of distribution to tissues, which partly explains 
their prolonged existence in the blood. Another factor that 
contributes to its prolonged half-life is the low rate of re-
nal excretion in relation to nicotine (Feyerabend, Russell, 
1980). Therefore, because of its longer half-life, cotinine 
is often the marker of choice to demonstrate exposure to 
cigarette smoke (Chadwick, Keevil, 2007).
A high pH was used in order to co-extract cotinine 
and lidocaine, with satisfactory extraction efficiency, since 
the pKa of cotinine was reported to be < 5.0 (Beckett, Gor-
rod, 1972) with basic characteristics. In this study, COT 
was extracted efficiently in chloroform, after alkalization 
with sodium hydroxide 5 mol L-1.
Linearity was determined for COT using a pool 
of blank urine that was spiked with the analyte and the 
internal standard. Peak area ratios (COT/IS) and analyte 
concentrations were found to be linear in the range eva-
luated. The least-squares linear regression was used to 
determine the slope and intercept. Man et al. (2006), using 
gas chromatography and mass spectrometry, obtained a 
linear range from 0.5 to 5000 ng mL-1.
The present study was proposed for determination of 
urinary cotinine of active, passive and non-smokers. The 
limit of quantification obtained (10 ng mL-1) was sufficient 
for monitoring passive smoking, because according to 
Kolonen & Pahukainen (1991), urinary cotinine levels 
in passive smokers are typically less than 100 ng mL-1, 
serving as a cut-off point to verify tobacco-free status. 
Other authors have suggested a cut-point of 50 ng mL-1 for 
urinary cotinine as a means to distinguish smokers from 
non-smokers (Haufroid, Lison, 1998; Song et al., 2005). 
Besides, zero cotinine concentration is generally observed 
in urine of non-smokers not exposed to environmental 
tobacco smoke.
In the present study with a nitrogen phosphorus 
detector, the method developed was able to distinguish 
different groups exposed to tobacco smoke, which can be 
considered an advantage in routine analysis. 
Intra- and inter-assay precision were less than 8.5% 
and 14.2%, respectively, and this is considered satisfac-
tory according to FDA guidelines (2001). This parameter 
should not exceed 15% of the RSD, except for the LOQ, 
where it should not exceed 20% of the RSD.
Relative recovery of COT was in the range of 88.5% 
and 108.2% with an accuracy in the range of -1.7 % and 
+11.9%. The guidance of validation for bioanalytical me-
thods of the FDA (2001) establishes that recovery of the 
analyte need not be 100%, where lower values are accep-
table provided the recovery offers precision and accuracy. 
Other studies (Voncken, Schepers, Schafer, 1989; Hagan 
et al., 1997; Ji Jr et al., 1999; Shin et al., 2002; Chadwick, 
Keevil, 2007) using liquid-liquid extraction as the sample 
preparation technique obtained recoveries of between 81 
and 112%.
Ruggedness was evaluated through the Youden ap-
proach and allowed the conclusion that small variations 
did not affect the method under tested conditions, since 
the results did not differ significantly across the conditions 
evaluated.
Cotinine concentrations observed in this study were 
2,980 ± 2,160 ng mL-1, for active smokers and 132.00 ± 
80 ng mL-1, for passive smokers, in line with urinary coti-
nine concentrations described in the literature (Voncken, 
Schepers, Schafer, 1989; Oddoze, Pauli, Pastor, 1998; 
Moyer et al., 2002; Ji Jr et al., 1999; Kuo, Yang, Chiu, 
2002; Man et al., 2006; Chadwick, Keevil, 2007) of 1,560 
to 6,680 ng mL-1, for active smokers and approximately 
50 ng mL-1, for passive smokers.
CONCLUSION
A fast and simple GC-NPD method was developed 
and validated for urinary cotinine analysis using a low 
sample volume. The results revealed that satisfactory 
chromatographic separation between the analyte and inter-
ferents was obtained with a ZB-1 column. This method is 
reliable, precise, linear and presented ruggedness over the 
range evaluated. The results suggest that it can be applied 
in routine analysis to passive and active smokers, since it 
is able to quantify a wide range of cotinine concentrations 
in urine.
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